← Leaderboards
Aaron Michael Ring
Stanford University
$3,624,309
Attributed
$4,683,241
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,683,241 · 4
By mechanism
DP5$2,093,750 · 1
R01$1,235,421 · 1
P50$1,233,314 · 1
F30$120,756 · 1
Top collaborators
- Charles S Dela Cruz1 shared
- Shelli Farhadian1 shared
- Tamas L Horvath1 shared
- Akiko Iwasaki1 shared
- Shuangge Ma1 shared
- David Van Dijk1 shared
Most similar at Stanford University
Same institution · by research overlap
- Peter R Parham$35,417,272
- Robert S Negrin$29,816,136
- Ronald Levy$27,846,042
- Ann M Arvin$18,980,456
- Sheri M. Krams$11,764,466
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneCell PhysiologyMalignant NeoplasmsEngineeringSiteResponseImmunityTumorMediatingCancer TherapyKnock-OutPathway InteractionsImmunotherapeutic AgentImmune SystemResistanceAutoimmune ProcessCharacteristicsImmunotherapyNeoplastic CellEtiologyNovel StrategiesLigandsAllelesInterleukin-2
Grant awards (12)
Project 3. Overcoming Melanoma Treatment Resistance with Cytokine Immunotherapy$435,370
P50 · FY2025 · CA · contact PI
Project 3. Overcoming Melanoma Treatment Resistance with Cytokine Immunotherapy$414,525
P50 · FY2024 · CA · contact PI
Project 3. Overcoming Melanoma Treatment Resistance with Cytokine Immunotherapy$383,419
P50 · FY2023 · CA · contact PI
Viral and immune-mediated CNS pathology during SARS-CoV-2 infection$1,235,421
R01 · FY2022 · AI
Cell Death Sensing Pathways That Trigger Necroinflammation$418,750
DP5 · FY2020 · OD · contact PI
Cell Death Sensing Pathways That Trigger Necroinflammation$418,750
DP5 · FY2019 · OD · contact PI
Uncoupling pleiotropy in the LIGHT/HVEM/LTBetaR signaling network$418,750
DP5 · FY2018 · OD · contact PI
Uncoupling pleiotropy in the LIGHT/HVEM/LTBetaR signaling network$418,750
DP5 · FY2017 · OD · contact PI
Uncoupling pleiotropy in the LIGHT/HVEM/LTBetaR signaling network$418,750
DP5 · FY2016 · OD · contact PI
MOLECULAR ENGINEERING OF IL-2 FOR THE TREATMENT AND PREVENTION OF TYPE I DIABETES$36,724
F30 · FY2013 · DK · contact PI
MOLECULAR ENGINEERING OF IL-2 FOR THE TREATMENT AND PREVENTION OF TYPE I DIABETES$42,232
F30 · FY2012 · DK · contact PI
MOLECULAR ENGINEERING OF IL-2 FOR THE TREATMENT AND PREVENTION OF TYPE I DIABETES$41,800
F30 · FY2011 · DK · contact PI